Literature DB >> 18472940

Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis.

C Caruso1, G Candore, D Cigna, S Tripi, G Di Gaetano, G Migneco, G Montalto, I Ruggieri, A Notarbartolo.   

Abstract

The aim of the present study was to compare serum levels of soluble forms of interleukin-2 receptor, CD4 and CD8, released by lymphocytes during activation ofthe immune system, in patients with histologically verified chronic active hepatitis associated to hepatitis C virus infection, with those in healthy subjects. Significantly higher levels of soluble IL-2R and soluble CD8 were found in patients with chronic active hepatitis compared with controls. In contrast no difference was found for soluble CD4 values in the two groups. No correlations were found for both sIL-2R and sCD8 and these two molecules with other parameters of liver function. These results indicate that in these patients there is a general activation of the immune system, but the lack of correlation with parameters of liver function strengthens the suggestion that this activation does not play a role in the pathogenesis of chronic type C hepatitis.

Entities:  

Year:  1994        PMID: 18472940      PMCID: PMC2367042          DOI: 10.1155/S0962935194000256

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  15 in total

1.  Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection.

Authors:  N W Leung; J C Leung; J S Tam; J T Lau; K N Lai
Journal:  Am J Gastroenterol       Date:  1992-01       Impact factor: 10.864

2.  Soluble CD8 in patients with rheumatic diseases.

Authors:  J A Symons; N C Wood; F S di Giovine; G W Duff
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritis.

Authors:  C C Zielinski; B Pesau; C Müller
Journal:  Clin Immunol Immunopathol       Date:  1990-10

4.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection.

Authors:  P Botarelli; M R Brunetto; M A Minutello; P Calvo; D Unutmaz; A J Weiner; Q L Choo; J R Shuster; G Kuo; F Bonino
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

5.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  Soluble IL-2-receptor and CD8 in the serum and the periparasitic granuloma of patients with alveolar echinococcosis.

Authors:  S Bresson-Hadni; B Monnot-Jacquard; E Racadot; D Lenys; J P Miguet; D A Vuitton
Journal:  Eur Cytokine Netw       Date:  1991 Nov-Dec       Impact factor: 2.737

7.  Immunity in hepatitis C infection.

Authors:  A M Prince; B Brotman; T Huima; D Pascual; M Jaffery; G Inchauspé
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

8.  Lack of protective immunity against reinfection with hepatitis C virus.

Authors:  P Farci; H J Alter; S Govindarajan; D C Wong; R Engle; R R Lesniewski; I K Mushahwar; S M Desai; R H Miller; N Ogata
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

9.  Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis.

Authors:  J A Symons; J F McCulloch; N C Wood; G W Duff
Journal:  Clin Immunol Immunopathol       Date:  1991-07

10.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more
  1 in total

1.  Serum levels of soluble IL-2R, CD4 and CD8 in bronChial asthma.

Authors:  G D Lorenzo; P Mansueto; M Melluso; G Morici; F Norrito; D Cigna; G Candore; C Caruso
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.